This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Serological Transplant Diagnostics Market

Serological Transplant Diagnostics Market

Serological Transplant Diagnostics Market, Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2021 to 2031

Serological Transplant Diagnostics Market
  • Feb-2021
  • List of Tables : 33
  • List of Figures : 153
  • 170 Pages
  • Healthcare

About the Report

Cases of kidney, lung, liver, and heart damage have been rising steadily over the past decades.

While advancements in the medical & diagnostic sector are playing a vital role in raising the market value for serological transplant diagnostics, growing awareness regarding proper diagnosis remains another key growth factor.

Regional players across North America, Europe, and Asia Pacific are set to witness impressive growth over the coming years, while rise in requirement from hospitals and other key distribution channels will further cater market growth in future.

A new study by Fact.MR provides thorough analysis of the global serological transplant diagnostics market, along with insights of key driving & restraining factors, demand-supply trajectories, and new trends around the globe for the forecast period of 2021 to 2031.

The report tracks the industry in 20+high-growth markets, and also details how the COVID-19 pandemic is shaping market growth.

Historical & Future Market Outlook

Serological transplant diagnosis, being a highly significant part of successful and efficient organ transplantation, has gained rapid traction over the past years.

Growth in key distribution channels such as hospitals and organ transplantation centers, to name a few, has further raised demand during the last 5 years from 2016 to 2020, which, in turn, has attracted more stakeholders to this industry.

Rise in cases of serious lung, liver, and kidney diseases, and medical & diagnostic advancements, are fuelling the sales of serological transplant diagnostic equipment.

Additionally, various initiatives taken by leading health organizations such as the WHO (World Health Organization), CDC (Centers for Disease Control and Prevention), and others are aiding the growth of suppliers in this industry.

According to Fact.MR, the global serological transplant diagnostics market is set to expand at around 2.5% CAGR through 2031.

Know More Details About the Report

How is Rising Need for Organ Transplants Aiding Demand for Serological Transplant Diagnostics?

Prevalence of organ damage cases has substantially raised the demand for serological transplant diagnostic solutions since the past decade. According to a report published by the National Kidney Foundation, over 2 million people across the world currently receive treatment for kidney failure, while a majority are treated in only five countries - the United States, Japan, Germany, Brazil, and Italy.

As per the report, more than 80% of all patients who receive treatment for kidney failure are from affluent countries, with universal access to healthcare and a large elderly population.

As stated in a report titled “The Burden of Lung Diseases”, published by the ERS Organization, respiratory diseases are among the leading causes of death worldwide, while lung infections, lung cancer, and chronic obstructive pulmonary disease (COPD) together account for approximately 10 million deaths yearly. This indicates the rising need serological transplant diagnostic equipment across regions.

What are the Key Challenges Faced by Serology Transplant Diagnostic Equipment Suppliers?

While cases of kidney, heart, lung, and other organ damage are increasing steadily, there is still lack of knowledge and awareness regarding timely diagnosis and receiving proper treatment.

Furthermore, serological transplantation and diagnosis are quite expensive, and hence, not affordable by everyone.

As stated in a report published by NCBI, liver disease accounts for nearly 2 million deaths per year, worldwide. The fatality of liver, kidney, lung, and other organ damage is well-known, but still, organ transplants are yet to be widely adopted by patients who suffer from severe damage.

Manufacturers and suppliers of serological transplant diagnostics are investing their efforts to produce a broader range of affordable products as a solution to this issue.

serological transplant diagnostics market

Avail customized purchase options for your needs

Country-Wise Analysis

Why is the Serological Transplant Diagnostics Industry Anticipated to Exhibit Hegemony in the U.S.?

The United States is the leading country in North America as far as serological transplant diagnostics is concerned, and will witness impressive rise in demand over the coming years.

Highly advanced medical & diagnostic sectors coupled with rise in cases of severe kidney and heart diseases are fuelling the sales of manufacturers in the country.

As stated in a report titled “Heart Disease Facts”, published by CDC on 8th September 2020, heart disease cost the United States around US$ 219 billion each year from 2014 to 2015, which includes the cost of healthcare services, medicines, and lost productivity due to health.

As per the report, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States, and around 655,000 Americans die from heart disease, including heart damage, each year. As more people are becoming aware regarding the fatality of heart diseases, the rate of organ transplantation is rising in the U.S.

What Enables China to Maintain a Leading Market Position?

China, being the epicenter of the world’s fastest-growing market for serological transplant diagnostics, East Asia, is in the spotlight for manufacturers and suppliers in this industry.

Highly advanced diagnostics industry, and increase in cases of liver, kidney, and lung damage, are raising the revenue of players in in China.

As per data revealed by the China Governmental Statistical Survey, overall rate of survival in brain-dead donor single lung transplantation is more than 60%, while the same for double lung transplantation is more than 75%, as observed over the last 5 years.

This data gives a glimpse of new growth scope awaiting players dealing with serological transplant diagnostics in China.

How Lucrative Would Germany be for Providers of Serology Transplant Diagnostics?

Germany is the dominating country in Europe for serological transplant diagnostics, owing to surge in demand from highly developed hospitals and blood banks & transportation centers.

Additionally, rise in requirement in diverse applications such as liver transplantation, heart transplantation, and kidney transplantation is further catering to growth of the market.

According to a report published by the Germany Trade and Investment (GTAI) Organization, Germany’s healthcare market is number 1 in Europe by volume, number of patients, medical technology manufacturers, and healthcare providers. As per the report, Germany’s hospital industry is highly advanced, while healthcare spending in the country exceeded EUR 400 billion in 2019, and is growing further.

According to a report published by the PLOS Organization on 24th April 2020, in the adult German population, Chronic Kidney Disease (CKD) is estimated to have a prevalence between 2% to 7%, while a majority of CKD patients are classified as stage 3.

This is indirectly contributing to the rise in sales of serological transplant diagnostic equipment across the country.

Do Suppliers of Serological Transplant Diagnostic Equipment Need to Look at India?

India has emerged as another lucrative market for serological transplant diagnostics, and is expected to take its spot in the limelight for suppliers and manufacturers in this industry. Increase in cases of lung, heart, and kidney failure, coupled with steady growth of the healthcare & diagnostics industry is spurring growth in India.

According to a report titled “Chronic Kidney Disease in India”, published by the American Society of Nephrology on 7th May 2018, reported a prevalence of CKD in different regions across India ranges from 1% to 13%.

Recently, data from the International Society of Nephrology’s Kidney Disease Data Centre Study reported a prevalence of 17%, while the etiology of CKD varies considerably throughout India. These statistics give an idea regarding the upcoming opportunities in India for stakeholders in the serological transplant diagnostics space.

Category-Wise Insights

Which Product is Highly Sought-After for Serological Transplant Diagnostics?

According to Fact.MR, reagents & accessories, followed by systems, are dominating the global serological transplant equipment market in terms of product.

Reagents and accessories are an integral part of various types of serological transplant diagnostic tests such as blood type testing, Human Leukocyte Antigens (HLA) testing, and other serological tests, as they are highly useful and crucial for effective organ transplantation.

Which Transplantation Procedures Top the Application List?

Currently, rise in demand for serological transplant diagnosis is becoming more prevalent in applications such as kidney and liver transplantation. Increase in cases of kidney and liver damage is expected to further fuel the sales of manufacturers in this industry.

Some of the other key segments aiding market expansion in this category are heart and lung transplantation.

An Adaptive Approach to Modern-day Research Needs

Rise in Demand from Hospitals to Bolster Market Growth

With steady expansion of hospitals, demand for serological transplant diagnostic equipment is surging around the globe. According to the European Commission (EC), the EU hospitals and healthcare industry is growing fast, while contributing to nearly 2% of EU’s total manufacturing workforce.

Other key distribution channels are blood banks & transplant centers, donor registries, and research laboratories.

Competitive Landscape

The global serological transplant diagnostics market is fragmented in nature and thriving on potential players. In order to capitalize on new opportunities, key market players are diversifying their product portfolios. For instance,

  • Recently, Bag Health Care GmbH launched its wide range of serological transplant diagnostic solutions such as bag diagnostics microlymphocytotoxicity test, bag diagnostics histo trays, and others.
  • Siemens Healthineers expanded its serological testing domains, including SARS-CoV-2 Testing in 2020, in order to increase its sales footprint.

Have a report related query? Speak to us directly

Report Scope



Forecast Period


Historical Data Available for


Market Analysis

USD Million for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Middle East & Africa
  • Oceania

Key Countries Covered

  • US
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Poland
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Malaysia
  • Vietnam
  • Indonesia
  • Australia
  • New Zealand
  • GCC Countries
  • Turkey
  • Northern Africa
  • South Africa

Key Segments Covered

  • Product
  • Application
  • Distribution Channel
  • Region

Key Companies Profiled

  • Becton Dickinson & Company
  • ThermoFisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Agena Bioscience Inc.
  • Avioq Inc.
  • Bag Health Care GmbH
  • Immucor Inc.
  • Siemens Healthineers
  • Produkte GmbH

Report Coverage

  • Market Forecasts
  • Brand Share Analysis
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Market Segmentation by Category


  • Reagents & Accessories
  • Systems


  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Others

Distribution Channel

  • Hospitals
  • Blood Banks & Transplant Centres
  • Donor Registries & Research Laboratories


  • North America
  • Latin America
  • Europe
  • Middle East and Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

Serology Transplant Diagnostics Market - Scope of Report

A recent study by Fact.MR on the serology transplant diagnostics market offers a 10-year forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining market growth.

This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with the manufacturing of serology transplant diagnostic equipment.

The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period.

A detailed assessment of the value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the serology transplant diagnostics market, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including demand, product development, revenue generation, and sales in the serology transplant diagnostics market across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as conservative scenario, taking into account sales during the forecast period.

Price point comparison by region with global average price is also considered in the study.

Key Questions Answered in Report

  • Which are the most lucrative markets for serology transplant diagnostics?
  • Which factors will impact the growth of the serology transplant diagnostics market?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the serology transplant diagnostics industry?
  • What are the winning strategies of stakeholders in the market?

Inspected Assessment on Regional Segments

Key sections have been elaborated in the serology transplant diagnostics market report, which have helped deliver projections on regional markets.

These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.

Country-specific valuation on demand for serology transplant diagnostics has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries.

For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the serology transplant diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases.

Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.

- FAQs -

Some of the top companies providing serological transplant diagnostic equipment are Immucor Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., and ThermoFisher Scientific Inc.

The United States, Canada, China, Germany, The United Kingdom, Japan, France, and a few others are lucrative markets for serological transplant diagnostics, and are expected to dominate throughout the forecast period.

Presently, reagents & accessories are the mostly sought-after in terms of product, and are expected to keep leading over the forecast period as well.

Need an Exclusive Report for your Unique Requirement?

Talk Show:

The Rise of Intelligent Packaging

Personalized, Connected and Sustainable

November 18, 2021 11:00-11:45 AM PST (USA & Canada)
This is a LIVE session
Future Market Insights MarketNgage Spring

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.